REAL-WORLD COSTS IN BIOLOGIC NAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE

被引：0
|
作者：
Kaplan, D. [1 ]
Ung, B. [2 ]
Udeze, C. [3 ]
Pelletier, C. [3 ]
Tian, M. [3 ]
机构：
[1] Adult & Pediat Dermatol, Overland Pk, KS USA
[2] Celgene Corp, Morris Plains, NJ USA
[3] Celgene Corp, Summit, NJ USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS15
引用
收藏
页码：S888 / S888
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD COSTS IN BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE
    Kaplan, D.
    Ung, B.
    Pelletier, C.
    Udeze, C.
    Tian, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S888 - S888
  • [2] Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics
    Feldman, Steven R.
    Pelletier, Corey L.
    Wilson, Kathleen L.
    Mehta, Rina K.
    Brouillette, Matthew A.
    Smith, David
    Bonafede, Machaon M.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (01) : 45 - 54
  • [3] COMPARISON OF PERSISTENCE AND ADHERENCE IN BIOLOGIC NAIVE PATIENTS WITH PSORIATIC ARTHRITIS INITIATING APREMILAST OR BIOLOGICS IN A US ADMINISTRATIVE CLAIMS DATABASE
    Feldman, S. R.
    Bonafede, M. M.
    Pelletier, C.
    Mehta, R.
    Brouillette, M.
    Smith, D.
    Wilson, K. L.
    Ni, Q.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A541 - A541
  • [4] Real-world switch patterns and healthcare costs in biologic-naive psoriasis patients initiating apremilast or biologics
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    Khilfeh, Ibrahim
    Curtis, Jeffrey R.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (11) : 767 - 779
  • [5] RATES OF REAL-WORLD TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE
    Kaplan, D.
    Ung, B.
    Pelletier, C.
    Udeze, C.
    Tian, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S245 - S245
  • [6] Treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriatic arthritis: results from a US claims analysis
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (01) : 169 - 176
  • [7] Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (04) : 365 - 371
  • [8] Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis
    Feldman, Steven R.
    Pelletier, Corey L.
    Wilson, Kathleen L.
    Mehta, Rina K.
    Brouillette, Matthew A.
    Smith, David
    Bonafede, Machaon M.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (09) : 699 - 708
  • [9] SWITCH PATTERNS AND TOTAL HEALTHCARE COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIATIC ARTHRITIS: RESULTS FROM A US CLAIMS ANALYSIS
    Curtis, J. R.
    Pelletier, C.
    Ung, B.
    Tian, M.
    Ni, Q.
    Wu, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S293 - S294
  • [10] REAL-WORLD SWITCH RATES AMONG BIOLOGIC-NAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING APREMILAST, TUMOR NECROSIS FACTOR INHIBITORS OR INTERLEUKIN INHIBITORS
    Kaplan, David
    Ung, Brian
    Pelletier, Corey
    Udeze, Chuka
    Tian, Marc
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1287 - 1287
12345